Liraglutide A retrospective observational study investigated 158 obese patients with T2D who were treated with LIRA (starting from a daily dose of 0.6 mg that was increased over 1 week to 1.2 mg/day) at least 3 months before study enrolment [69]
1 Introduction Taste perception represents a sophisticated biological system that transcends mere flavor detection, functioning as a vital nexus connecting nutritional sensing, metabolic control, and eating patterns
1 This translates into a lower risk of hypoglycemia compared to other diabetes treatment options like sulfonylureas and insulin
Michigan BCBS implemented what amounted to a near-complete removal of weight loss indication coverage, with narrow exceptions for members who could demonstrate specific comorbidities beyond obesity alone
The first DPP-4 inhibitor, sitagliptin, was approved by the FDA in 2006 and by the EMA in 2007
Support Gut Health with GLP1 Probiotics Probiotics like Lactobacillus and Bifidobacterium strains help maintain a healthy gut microbiome that enhances GLP-1 production
